References for Supratentorial Low-Grade Gliomas in Children

  1. Louis DN, Ohgaki H, Wiestler OD, et al: WHO Classification of Tumors of the Central Nervous System, ed 3. Lyon, France:IARC Press, 2007
  2. Lantos PL, Louis DN, Rosenblum MK, et al: Tumours of the nervous system, in Grahams DI, Lantos PL (eds): Greenfield’s Neuropathology, ed 7. London: Arnold, 2002. pp 770-781
  3. Escalona-Zapata J. Clasificaciones, in Tumores del Sistema Nervioso Central. Madrid: Editorial Complutense, 1996, pp 13-25
  4. Peraud A, Ansari H, Bise K, et al: Clinical outcome of supratentorial astrocytoma WHO grade II. Acta Neurochir (Wien) 140:1213-1222, 1998
  5. Ichimura K, Bolin MB, Goike HM, et al: Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 60:417-424, 2000
  6. Lebrun C, Fontaine D, Ramaioli A, et al: Long-term outcome of oligodendrogliomas. Neurology 62:1783-1787, 2004
  7. Ohgaki H, Kleihues P: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479-489, 2005
  8. Van der Bent MJ, Afra D, de Witte O, et al: Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985-990, 2005
  9. Schiffer D, Chio A, Giordana MT, et al: Histologic prognostic factors in ependymoma. Childs Nerv Syst 7:177-182, 1991
  10. Chang EF, Potts MB, Keles GE, et al: Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227-235, 2008
  11. Lee YY, Van TP: Intracranial oligodendrogliomas: imaging findings in 35 untreated cases. Am J Roentgenol 152:361-369, 1989
  12. Al Okaili RN, Krejza J, Woo JH, et al: Intraaxial brain masses: MR imaging-based diagnostic strategy – initial experience. Radiology 243:539-550, 2007
  13. Muti M, Aprile I, Principi M, et al: Study on the variations of the apparent diffusion coefficient in areas of solid tumor in high-grade gliomas. Magn Reson Imaging 20: 635-641, 2002
  14. Smits A, Duffau H: Seizures and the natural history of World Health Organization grade II gliomas a review. Neurosurgery 68: 1326-1333, 2011
  15. Rutten GJ, Ramsy NF, Van Rijen PC, et al: Development of a functional magnetic resonance imaging protocol for intraoperative localization of critical temporoparietal language areas. Ann Neurol 51:350-360, 2002
  16. Rutten GJ, Ramsey N, Noordmans HJ: Toward functional neuronavigation: implementation of functional magnetic resonance imaging data in a surgical guidance system for intraoperative identification of motor and language cortices. Technical note and illustrative case. Neurosurg Focus 15: E6-8, 2003
  17. Klein M, Heimans JJ, Aaronson NK, et al: Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. The Lancet 360: 1361-1368, 2002
  18. Kiebert GM, Curran D, Aaronson NK, et al: Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844). Eur J Cancer 34: 1902-1909, 1998
  19. Pouration N, Gasco J, Sherman JH, et al: Toxicity and efficacy of protacted low dose temozolamide for the treatment of low grade gliomas. J Neurooncol 82: 281-288, 2007
  20. Ricard D, Kalosyi G, Amiel-Benouaich A, et al: Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol 61: 484-490, 2007
  21. Johnson JHJ, Hariharan S, Berman J, et al: Clinical outcome of pediatric gangliomas: ninety-nine cases over 20 years. Pediatr Neurosurg 27:203–207, 1997
  22. CBTRUS, Table 8: Number of childhood cases by major histology groupings, histology and age at diagnosis, CBTRUS, 2000-2004, 16 states combined. Hinsdale, Il: Central Brain Tumor Registry of the United States, 2008 (http://www.cbtrus.org)
  23. Wisoff JH, Sanford RA, Heier LA, et Al: Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children’s Oncology Group. Neurosurgery 68: 1548-1554, 2011
  24. Laigle-Donadey F, Benouaich-Amiel A, Hoang-Xuan K, et al: Molecular biology of oligodendroglial tumors. Neuro-Chirurgie 51 (3-4 Pt 2): 260–268, 2005
  25. Walker C, Haylock B, Husband D, et al: Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors. Neurology 66: 1661–1667, 2006
  26. Kernohan JW, Mabon RF, Svien HJ, et al: A simplified classification of gliomas. Proc Staff Meet Mayo Clin. 24: 71-75, 1949
  27. Zülch KJ:[Outlines to simplify classification of neuroepithelial neoplasms]. Acta Neurochir (Wien) 3:104-10, 1952
  28. Zülch KJ:[Classification of brain tumors. Recent acquisitions on experimental tumors of the nervous system]. Riv Anat Patol Oncol 36:1-17, 1970
  29. Gilles FH: Classifications of childhood brain tumors. Cancer 56 (7 Suppl):1850-1857, 1985
  30. Kleihues P, Kiessling M, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3: 255-268, 1987
  31. Stander M, Peraud A, Leroch B, et al: Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization grade II astrocytoma or oligoastrocytoma: a long-term analysis. Cancer 101: 1028–1035, 2004